Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQCommunication ServicesBroadcastingSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
2.40 → 2.40 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for XHLD yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Meet Nasdaq equity standards to avoid delisting | The company aims to fix Nasdaq listing issues. | Intact | receives further Nasdaq deficiency notices or delisting | Qualitative condition This condition has no defined numerical measure. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making business with volatile management and a sector backdrop marked as a headwind. The long-term thesis is in a watch state: recent performance is weak, and total stock risk has risen, while evidence of progress on management’s priorities remains limited.
The valuation model shows XHLD at a 1.19 premium versus peers, with medium confidence and valuation divergence marked as aligned. The evidence does not state specific market expectations, so how much future improvement is already assumed is unclear. Fragility is rated low, but that does not remove the business risks.
Near term, earnings risk is elevated, with a 0.71 estimated miss probability after misses across recent quarters. Second-quarter revenue was $731,000, down from $1.1 million a year earlier; cash rose to $5.8 million from $1.6 million at the start of the year after an offering. Management has stated priorities around working capital, AI and product development, and acquisitions, but delivery evidence is partial or limited, and a possible guidance cut is a key risk.
The multi-year thesis hinges on management turning improved liquidity into stronger working capital and showing measurable progress in product development and recurring revenue. Near term, a guidance cut would deepen concern, while Federal Reserve rate cuts or continued earnings strength among sector peers could support the sector backdrop.
Over the next 1 to 3 years, XHLD’s thesis depends on a clear improvement in results and execution, with current evidence still weak and risk high. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| It plans to reduce its operating losses from -$2.8 million. |
| Intact |
| operating loss worsens beyond -$2.8 million next quarter |
Operating income: $-2.993M FY2026-Q2; GAAP. Published target: operating loss less negative than -$2,843,000. The target does not explicitly identify fiscal versus calendar quarters. Aug 10, 2026-2,993,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “Because these costs are largely fixed while the Company’s revenue remains relatively small, quarter-to-quarter changes in revenue can have an outsized effect on reported operating results.” ““We remain committed to prudent capital allocation and financial discipline as we scale, and we believe the combination of an improving cost structure, a strengthened balance sheet, and a clear strategic roadmap positions TEN Holdings to build long-term value for our shareholders.”” Delivery assessment Nov 5, 2026 |
Increase revenue to at least $853,000 next quarter | A primary condition in TEN HOLDINGS INC's published investment case. The stated target is >= $853,000. | Broken | revenue falls below $700,000 next quarter | Revenue: $731,000 FY2026-Q2; GAAP. Published target: >= $853,000. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Aug 10, 2026731,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$2.40 → $2.40 · observed estimates
$0.01B → $0.01B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-07-25 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-07-26 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-07-27 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-07-28 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-07-29 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-07-30 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-07-31 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-01 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-02 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-03 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-04 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-05 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-06 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-08 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-09 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-10 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-12 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-13 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-14 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-15 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-16 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-17 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-18 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-19 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-20 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-21 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-22 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-23 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-24 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-25 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-26 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-27 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-28 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-29 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-30 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-08-31 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-01 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-02 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-03 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-04 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-05 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-06 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-07 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-08 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-09 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-10 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-11 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-12 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-13 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-14 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-15 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-16 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-17 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-18 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-19 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-20 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-21 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-22 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-23 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-24 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-25 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-26 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-27 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-28 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-29 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-09-30 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-01 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-02 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-03 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-04 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-05 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-06 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-07 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-08 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-09 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-10 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-11 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-12 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-13 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-14 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-15 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-16 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-17 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-18 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-19 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-20 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-21 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-22 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-23 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-24 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-25 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-26 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-27 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-28 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-29 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-30 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-10-31 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-11-01 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-11-02 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-11-03 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-11-04 | $2.40 | $11,200,000 | 1 / 1 |
| 2026-11-05 | $2.40 | $11,200,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Monthly analyst history is unavailable.
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.